13F filer · CIK 1819257
Patient Square Capital LP
MENLO PARK, CA · filing since Q4 2022 · last filing Aug 12, 2026
Reported value
$645.5M
+$81.9M vs prior
Positions
23
New / sold out
6 / 12
Added / reduced
9 / 8
Turnover
23.4%
buys $141.3M · sells $146.2M
Top-10 weight
80.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | REVOLUTION MEDICINES INC | +276,000 | – | +$51.7M |
| New | UNITED THERAPEUTICS CORP DEL | +37,120 | – | +$20.1M |
| New | BIONTECH SE | +134,429 | – | +$12.5M |
| Added | ABIVAX SA | +85,255 | +70.3% | +$11.4M |
| New | C4 THERAPEUTICS INC | +1,608,815 | – | +$7.5M |
| New | INVENTIVA SA | +1,967,171 | – | +$7.4M |
| Added | PHARVARIS N V | +178,209 | +36.1% | +$6.2M |
| Added | ARCUS BIOSCIENCES INC | +160,800 | +82.5% | +$5.0M |
| New | FAETH THERAPEUTICS INC | +175,050 | – | +$4.4M |
| Added | MIRUM PHARMACEUTICALS INC | +30,500 | +13.3% | +$3.6M |
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | INSMED INC | -157,500 | -100.0% | $-25.8M |
| Sold out | LEGEND BIOTECH CORP | -990,000 | -100.0% | $-17.9M |
| Sold out | NEKTAR THERAPEUTICS | -210,000 | -100.0% | $-15.1M |
| Reduced | ARGENX SE | -13,718 | -37.4% | $-12.7M |
| Sold out | CELCUITY INC | -95,000 | -100.0% | $-10.8M |
| Sold out | MERCK & CO INC | -80,000 | -100.0% | $-9.6M |
| Sold out | PERSPECTIVE THERAPEUTICS INC | -1,625,000 | -100.0% | $-6.8M |
| Reduced | COGENT BIOSCIENCES INC | -171,000 | -28.7% | $-6.6M |
| Sold out | DEFINIUM THERAPEUTICS INC | -331,000 | -100.0% | $-6.3M |
| Reduced | KYMERA THERAPEUTICS INC | -52,500 | -52.5% | $-6.0M |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTDSHS | 8,020,928 | $283.9M | 43.97% |
| 2 | REVOLUTION MEDICINES INCCOM | 276,000 | $51.7M | 8.01% |
| 3 | MIRUM PHARMACEUTICALS INCCOM | 260,500 | $30.5M | 4.72% |
| 4 | ABIVAX SASPONSORED ADS | 206,500 | $27.5M | 4.26% |
| 5 | BEONE MEDICINES LTDSPONSORED ADS | 90,020 | $25.7M | 3.97% |
| 6 | PHARVARIS N VCOM | 671,209 | $23.2M | 3.60% |
| 7 | ARGENX SESPONSORED ADR | 23,000 | $21.3M | 3.31% |
| 8 | UNITED THERAPEUTICS CORP DELCOM | 37,120 | $20.1M | 3.12% |
| 9 | BELITE BIO INCSPONSORED ADS | 110,000 | $16.9M | 2.62% |
| 10 | COGENT BIOSCIENCES INCCOM | 425,000 | $16.4M | 2.55% |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.